☆ 4.6 Editorial Material

Re: Phase I Clinical Trial of a Selective inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

EUROPEAN UROLOGY (2008)

Get Full Text
Add to Collection

Journal

EUROPEAN UROLOGY
Volume 54, Issue 6, Pages 1438-1439

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.eururo.2008.08.043

Keywords

-

Categories

Urology & Nephrology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.